ES2601890T3 - Identificación de regiones de estimulación diana asociadas a resultados clínicos terapéuticos y no terapéuticos para estimulación neural - Google Patents
Identificación de regiones de estimulación diana asociadas a resultados clínicos terapéuticos y no terapéuticos para estimulación neural Download PDFInfo
- Publication number
- ES2601890T3 ES2601890T3 ES11777000.8T ES11777000T ES2601890T3 ES 2601890 T3 ES2601890 T3 ES 2601890T3 ES 11777000 T ES11777000 T ES 11777000T ES 2601890 T3 ES2601890 T3 ES 2601890T3
- Authority
- ES
- Spain
- Prior art keywords
- patient
- stimulation
- region
- electrode
- axonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 146
- 230000001537 neural effect Effects 0.000 title claims abstract description 41
- 230000001225 therapeutic effect Effects 0.000 title claims description 47
- 230000003376 axonal effect Effects 0.000 claims abstract description 84
- 210000003050 axon Anatomy 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims description 53
- 210000004556 brain Anatomy 0.000 claims description 46
- 230000004913 activation Effects 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 25
- 230000037361 pathway Effects 0.000 claims description 25
- 238000009792 diffusion process Methods 0.000 claims description 23
- 210000001030 ventral striatum Anatomy 0.000 claims description 15
- 210000001009 nucleus accumben Anatomy 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 12
- 210000003484 anatomy Anatomy 0.000 claims description 11
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 11
- 230000002490 cerebral effect Effects 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 10
- 230000036982 action potential Effects 0.000 claims description 7
- 210000005013 brain tissue Anatomy 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000005094 computer simulation Methods 0.000 claims description 4
- 210000004001 thalamic nuclei Anatomy 0.000 claims description 3
- 238000003325 tomography Methods 0.000 claims 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 30
- 230000006872 improvement Effects 0.000 description 20
- 230000004044 response Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 208000035475 disorder Diseases 0.000 description 11
- 210000001029 dorsal striatum Anatomy 0.000 description 11
- 230000005684 electric field Effects 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 208000020016 psychiatric disease Diseases 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 238000002591 computed tomography Methods 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 210000002425 internal capsule Anatomy 0.000 description 7
- 230000000926 neurological effect Effects 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 description 5
- 102100031083 Uteroglobin Human genes 0.000 description 5
- 108090000203 Uteroglobin Proteins 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 210000004885 white matter Anatomy 0.000 description 4
- 208000012902 Nervous system disease Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 238000013528 artificial neural network Methods 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 210000001159 caudate nucleus Anatomy 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 210000005056 cell body Anatomy 0.000 description 2
- 210000004720 cerebrum Anatomy 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 210000001787 dendrite Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001103 thalamus Anatomy 0.000 description 2
- 238000013334 tissue model Methods 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000020925 Bipolar disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010054089 Depressive symptom Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108010052164 Sodium Channels Proteins 0.000 description 1
- 102000018674 Sodium Channels Human genes 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- ILSQBBRAYMWZLQ-UHFFFAOYSA-N n-(1,3-benzothiazol-2-ylsulfanyl)-n-propan-2-ylpropan-2-amine Chemical compound C1=CC=C2SC(SN(C(C)C)C(C)C)=NC2=C1 ILSQBBRAYMWZLQ-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000007604 neuronal communication Effects 0.000 description 1
- 230000002450 orbitofrontal effect Effects 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000002739 subcortical effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
- A61N1/36185—Selection of the electrode configuration
Landscapes
- Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Developmental Disabilities (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39460910P | 2010-10-19 | 2010-10-19 | |
| US394609P | 2010-10-19 | ||
| PCT/US2011/056898 WO2012054612A1 (en) | 2010-10-19 | 2011-10-19 | Methods for identifying target stimulation regions associated with therapeutic and non-therapeutic clinical outcomes for neural stimulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2601890T3 true ES2601890T3 (es) | 2017-02-16 |
Family
ID=44903419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11777000.8T Active ES2601890T3 (es) | 2010-10-19 | 2011-10-19 | Identificación de regiones de estimulación diana asociadas a resultados clínicos terapéuticos y no terapéuticos para estimulación neural |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8649845B2 (https=) |
| EP (1) | EP2629840B1 (https=) |
| JP (1) | JP2013540043A (https=) |
| AU (1) | AU2011317137B9 (https=) |
| CA (1) | CA2815507C (https=) |
| ES (1) | ES2601890T3 (https=) |
| WO (1) | WO2012054612A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011044442A1 (en) * | 2009-10-08 | 2011-04-14 | Mcw Research Foundation, Inc. | Method for determining locations of implanted electrodes with medical images |
| JP6027392B2 (ja) * | 2012-10-19 | 2016-11-16 | 株式会社ブリヂストン | 非空気入りタイヤ |
| US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
| EP3441109A1 (en) | 2013-05-30 | 2019-02-13 | Graham H. Creasey | Flexible dermal patch for a topical nerve stimulator system |
| AU2014348865B2 (en) * | 2013-11-14 | 2017-06-01 | Boston Scientific Neuromodulation Corporation | Systems, methods, and visualization tools for stimulation and sensing of neural systems with system-level interaction models |
| WO2015149170A1 (en) * | 2014-03-31 | 2015-10-08 | Functional Neuromodulation, Inc. | Systems and methods for determining a trajectory for a brain stimulation lead |
| US20170091386A1 (en) | 2014-05-16 | 2017-03-30 | Brainlab Ag | Inference Transparency System for Image-Based Clinical Decision Support Systems |
| US10583293B2 (en) | 2014-09-09 | 2020-03-10 | Medtronic, Inc. | Therapy program selection for electrical stimulation therapy based on a volume of tissue activation |
| EP3204112A1 (en) | 2014-10-07 | 2017-08-16 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
| CA2969425A1 (en) * | 2014-12-01 | 2016-06-09 | The Feinstein Institute For Medical Research | Use of striatal connectivity patterns for evaluating antipsychotic agents |
| WO2016090239A1 (en) * | 2014-12-05 | 2016-06-09 | Rush University Medical Center | Electrode placement and treatment system and method of use thereof |
| US11026626B2 (en) | 2015-01-19 | 2021-06-08 | Brainlab Ag | Tissue-orientation-based simulation of deep brain stimulation |
| US10622107B2 (en) | 2015-02-13 | 2020-04-14 | Medtronic, Inc. | Tools for medical device configuration |
| US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
| US10188863B2 (en) | 2015-02-26 | 2019-01-29 | Medtronic, Inc. | Therapy program selection for electrical stimulation therapy based on a volume of tissue activation |
| WO2017048908A1 (en) * | 2015-09-17 | 2017-03-23 | Albany Medical College | Stimulation of the ventral pallidum for the treatment of epilepsy |
| US10561848B2 (en) | 2015-10-13 | 2020-02-18 | Regents Of The University Of Minnesota | Systems and methods for programming and operating deep brain stimulation arrays |
| US10426949B2 (en) | 2016-10-26 | 2019-10-01 | Regents Of The University Of Minnesota | Systems and methods for optimizing programming and use of neuromodulation systems |
| WO2018091331A1 (en) * | 2016-11-17 | 2018-05-24 | Brainlab Ag | Time-synchronized deep brain stimulation optimization |
| WO2018157909A1 (en) * | 2017-02-28 | 2018-09-07 | Brainlab Ag | Optimal deep brain stimulation electrode selection and placement on the basis of stimulation field modelling |
| US11357986B2 (en) | 2017-04-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
| EP3651849B1 (en) | 2017-07-14 | 2023-05-31 | Boston Scientific Neuromodulation Corporation | Estimating clinical effects of electrical stimulation |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| WO2019094365A1 (en) | 2017-11-07 | 2019-05-16 | Neurostim Oab, Inc. | Non-invasive nerve activator with adaptive circuit |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US10543361B2 (en) * | 2018-02-20 | 2020-01-28 | General Electric Company | System and method for localization of deep brain stimulation electrode via magnetic resonance imaging |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| JP7295141B2 (ja) | 2018-04-27 | 2023-06-20 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | マルチモード電気刺激システム及び製造する及び使用する方法 |
| US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| CA3144957A1 (en) | 2019-06-26 | 2020-12-30 | Neurostim Technologies Llc | Non-invasive nerve activator with adaptive circuit |
| WO2021126921A1 (en) | 2019-12-16 | 2021-06-24 | Neurostim Solutions, Llc | Non-invasive nerve activator with boosted charge delivery |
| US12403315B2 (en) | 2021-04-27 | 2025-09-02 | Boston Scientific Neuromodulation Corporation | Systems and methods for automated programming of electrical stimulation |
| WO2022265977A1 (en) | 2021-06-15 | 2022-12-22 | Boston Scientific Neuromodulation Corporation | Methods and systems for estimating neural activation by stimulation using a stimulation system |
| US12527956B2 (en) | 2021-12-09 | 2026-01-20 | Boston Scientific Neuromodulation Corporation | Methods and systems for monitoring or assessing movement disorders or other physiological parameters using a stimulation system |
| US12471831B2 (en) | 2021-12-10 | 2025-11-18 | Boston Scientific Neuromodulation Corporation | Systems and methods for generating and using response maps for electrical stimulation |
| WO2023167872A1 (en) | 2022-03-02 | 2023-09-07 | Boston Scientific Neuromodulation Corporation | Systems and methods for monitoring stimulation drift in an electrical stimulation system |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6246912B1 (en) * | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
| WO2001037717A2 (en) * | 1999-11-26 | 2001-05-31 | Applied Spectral Imaging Ltd. | System and method for functional brain mapping |
| US6778846B1 (en) * | 2000-03-30 | 2004-08-17 | Medtronic, Inc. | Method of guiding a medical device and system regarding same |
| US7305268B2 (en) * | 2000-07-13 | 2007-12-04 | Northstar Neurscience, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
| US7299096B2 (en) * | 2001-03-08 | 2007-11-20 | Northstar Neuroscience, Inc. | System and method for treating Parkinson's Disease and other movement disorders |
| WO2003005887A2 (en) * | 2001-07-11 | 2003-01-23 | Nuvasive, Inc. | System and methods for determining nerve proximity, direction, and pathology during surgery |
| AU2003297761A1 (en) * | 2002-12-09 | 2004-06-30 | Northstar Neuroscience, Inc. | Methods for treating neurological language disorders |
| US8180601B2 (en) * | 2006-03-09 | 2012-05-15 | The Cleveland Clinic Foundation | Systems and methods for determining volume of activation for deep brain stimulation |
| US7346382B2 (en) * | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
| US8209027B2 (en) | 2004-07-07 | 2012-06-26 | The Cleveland Clinic Foundation | System and method to design structure for delivering electrical energy to tissue |
| US20100331883A1 (en) * | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
| US8374696B2 (en) * | 2005-09-14 | 2013-02-12 | University Of Florida Research Foundation, Inc. | Closed-loop micro-control system for predicting and preventing epileptic seizures |
| WO2007103475A2 (en) * | 2006-03-07 | 2007-09-13 | Beth Israel Deaconess Medical Center, Inc. | Transcranial magnetic stimulation (tms) methods and apparatus |
| US7949401B2 (en) * | 2006-04-11 | 2011-05-24 | Advanced Neuromodulation Systems, Inc. | Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods |
| US8401609B2 (en) * | 2007-02-14 | 2013-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | System, method and applications involving identification of biological circuits such as neurological characteristics |
| US8910638B2 (en) * | 2007-05-09 | 2014-12-16 | Massachusetts Institute Of Technology | Methods and apparatus for high-throughput neural screening |
| WO2009120836A1 (en) * | 2008-03-26 | 2009-10-01 | Neurosigma, Inc. | Methods for identifying and targeting autonomic brain regions |
| US8262714B2 (en) * | 2008-08-05 | 2012-09-11 | Advanced Neuromodulation Systems, Inc. | Techniques for selecting signal delivery sites and other parameters for treating depression and other neurological disorders, and associated systems and methods |
| US9095303B2 (en) * | 2009-03-23 | 2015-08-04 | Flint Hills Scientific, Llc | System and apparatus for early detection, prevention, containment or abatement of spread abnormal brain activity |
| WO2011011554A1 (en) * | 2009-07-21 | 2011-01-27 | The Regents Of The University Of California | Methods for the identification and targeting of brain regions and structures and treatments related thereto |
| WO2011068997A1 (en) * | 2009-12-02 | 2011-06-09 | The Cleveland Clinic Foundation | Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming |
| US8679009B2 (en) * | 2010-06-15 | 2014-03-25 | Flint Hills Scientific, Llc | Systems approach to comorbidity assessment |
| US8951192B2 (en) * | 2010-06-15 | 2015-02-10 | Flint Hills Scientific, Llc | Systems approach to disease state and health assessment |
-
2011
- 2011-10-19 JP JP2013535044A patent/JP2013540043A/ja active Pending
- 2011-10-19 US US13/317,459 patent/US8649845B2/en active Active
- 2011-10-19 WO PCT/US2011/056898 patent/WO2012054612A1/en not_active Ceased
- 2011-10-19 AU AU2011317137A patent/AU2011317137B9/en active Active
- 2011-10-19 CA CA2815507A patent/CA2815507C/en active Active
- 2011-10-19 ES ES11777000.8T patent/ES2601890T3/es active Active
- 2011-10-19 EP EP11777000.8A patent/EP2629840B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2629840B1 (en) | 2016-08-17 |
| US20120116211A1 (en) | 2012-05-10 |
| US8649845B2 (en) | 2014-02-11 |
| JP2013540043A (ja) | 2013-10-31 |
| AU2011317137B2 (en) | 2016-01-07 |
| WO2012054612A1 (en) | 2012-04-26 |
| CA2815507C (en) | 2021-07-20 |
| EP2629840A1 (en) | 2013-08-28 |
| AU2011317137A8 (en) | 2013-08-01 |
| AU2011317137B9 (en) | 2016-01-21 |
| CA2815507A1 (en) | 2012-04-26 |
| AU2011317137A1 (en) | 2013-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2601890T3 (es) | Identificación de regiones de estimulación diana asociadas a resultados clínicos terapéuticos y no terapéuticos para estimulación neural | |
| Lujan et al. | Axonal pathways linked to therapeutic and nontherapeutic outcomes during psychiatric deep brain stimulation | |
| Dembek et al. | Probabilistic sweet spots predict motor outcome for deep brain stimulation in Parkinson disease | |
| ES2741828T3 (es) | Sistema y procedimiento para definir el volumen objetivo para estimulación en el cerebro | |
| Middlebrooks et al. | Connectivity correlates to predict essential tremor deep brain stimulation outcome: evidence for a common treatment pathway | |
| Noecker et al. | StimVision v2: examples and applications in subthalamic deep brain stimulation for Parkinson’s disease | |
| Cheung et al. | Defining a therapeutic target for pallidal deep brain stimulation for dystonia | |
| Möttönen et al. | Defining the anterior nucleus of the thalamus (ANT) as a deep brain stimulation target in refractory epilepsy: delineation using 3 T MRI and intraoperative microelectrode recording | |
| US7957808B2 (en) | System and methods of deep brain stimulation for post-operation patients | |
| Kahane et al. | Reappraisal of the human vestibular cortex by cortical electrical stimulation study | |
| Montgomery Jr | Microelectrode targeting of the subthalamic nucleus for deep brain stimulation surgery | |
| Anderson et al. | Surgery insight: deep brain stimulation for movement disorders | |
| Van Dijk et al. | A novel lead design enables selective deep brain stimulation of neural populations in the subthalamic region | |
| Persson et al. | Deep brain stimulation of caudal zona incerta for Parkinson's disease: one-year follow-up and electric field simulations | |
| Bériault et al. | Towards computer-assisted deep brain stimulation targeting with multiple active contacts | |
| ES3041740T3 (en) | Methods for selective activation of central thalamus fibers in a subject and systems therefor | |
| Alonso | Models and Simulations of the Electric Field in Deep Brain Stimulation: Comparison of Lead Designs, Operating Modes and Tissue Conductivity | |
| Andrews et al. | Directional deep brain stimulation for cervical dystonia: Outcomes, challenges and future directions | |
| Sánchez-Gómez et al. | Utility of postoperative imaging software for deep brain stimulation targeting in patients with movement disorders | |
| Åström | Modelling, simulation, and visualization of deep Brain stimulation | |
| García Cornet | Deep Brain Stimulation lead reconstruction and computer simulation based on neuroimaging for patients with Parkinson’s disease | |
| US20250352268A1 (en) | Method and apparatus for planning placement of an implant | |
| Patrick et al. | Modeling the volume of tissue | |
| Bower | Factors affecting the predictive ability of computational models of subthalamic deep brain stimulation | |
| Baumgarten et al. | Image-guided preoperative prediction of pyramidal tract side effect in deep brain stimulation |